Presented by myTomorrows: Motivations for Pursuing Expanded Access: Strategic Value and Drivers for Stakeholders
Time: 2:00 pm
day: Conf Day One
Details:
- Explain the strategic benefits of initiating Expanded Access Programs (EAPs) early in drug development, including their role in generating real-world insights, informing clinical and commercial strategies, and supporting global access planning
- Identify key stakeholder engagement opportunities, including with KOLs, patient advocacy groups, regulators, payers, and internal teams, and describe how Expanded Access fosters collaboration, trust, and early alignment across the development lifecycle
- Discuss the operational and logistical considerations for implementing EAPs effectively, including proactive planning for supply, data collection, and regulatory coordination
